Chat with us, powered by LiveChat


Leveraging Patient-Centric Data Analytics to Accelerate Clinical Trials

Director of Marketing Programs, Crystal Black, detailed the significant applications of AI-fueled data analytics in the life sciences industry in this fascinating article on PharmaVoice.  “A qualified data analytics partner brings a variety of benefits to the table that enable sponsors to overcome these and other obstacles to leverage AI solutions that accelerate clinical trials.…

Read More

AI IRL Podcast: Can AI Save Billions in Clinical Research Costs?

When the cost of drug development has increased a few hundred fold, how do you find a way to cut expenses and time? AI to the rescue. AI is poised to make a major change in the economics of medical research, according to Crystal Black, Director of Marketing Programs for Saama Technologies. “We’re geared toward the mission…

Read More

Saama Challenges Analytics Industry to Guarantee Data Platforms to Help Accelerate Drug Development

Company Leads Call-to-Action by Issuing Saama Product Guarantee on Clinical Trials Day CAMPBELL, CA – (May 20, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics company, issued a call-to-action on Clinical Trials Day urging the analytics industry to commit to timely deployment of solutions for biopharmaceutical companies and the elimination of launch…

Read More

Board of Advisors Member, Opinder Bawa, Writes Article for

VP for Information Technology and Chief Information Officer at University of San Francisco and Saama Clinical Board of Advisors Member, Opinder Bawa, published an article on examining the role of AI in life science industry transformation through a historical lens. “Today we see how AI substantially increases or effectively disrupts clinical trial supply chain…

Read More

Saama’s Latest Funding Covered by Endpoints News

Saama’s recent $40M funding from Perceptive Advisors was covered by Endpoints News in an article reviewing Saama’s role in the adoption of artificial intelligence to speed up drug discovery and development. This article asserts that, “Optimization and efficiency are goals that everyone working in R&D can rally around, and AI promises to be a tool that…

Read More

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

CAMPBELL, CA – (March 25, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform disrupting the planning, designing and…

Read More

Saama Announced as a Finalist in Clinical Trial Process Innovation Category for 2019 Clinical & Research Excellence Awards

CAMPBELL, CA – (February 25, 2019) – Saama Technologies, Inc., a leading data analytics company, has been named a finalist in the Clinical Trial Process Innovation category for the 2019 Clinical & Research Excellence (CARE) Awards, which recognize outstanding work across the global clinical research enterprise. Saama was selected as a CARE Awards finalist in…

Read More

Saama VP, Malaikannan Sankarasubbu, Interviewed by Outsourcing-Pharma

Saama VP of AI Research, Malaikannan Sankarasubbu , was interviewed at SCOPE 2019 by Outsourcing-Pharma on the topic of  natural language processing as a solution to pharma’s “big text problem.” In the article, he is quoted, “Pharma has a lot of unstructured text, and the surface of this data has hardly been scratched in terms…

Read More

Related Posts